Skip to content

Blood Stream Infection: Focus On Outcomes - An observational study in patients with blood stream infections

Blood Stream Infection: Focus On Outcomes: A multicentre prospective observational study in patients with blood stream infections

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN09804912
Enrollment
2635
Registered
2013-10-08
Start date
2010-10-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Stream Infections Infections and Infestations Bacteraemia

Interventions

The study will be of a prospective cohort design and will involve the collection of data from each of the five centres Newcastle, Leeds, Cardiff, London and Bristol, to generate a large clinical libra

Sponsors

North Bristol NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18 years of age and over 2. Blood Stream Infection with one of the key pathogens plus Centres of Disease Control criteria for infection in the urinary tract, surgical site, pneumonia, blood stream, bone and joint, central nervous system, cardiovascular system, ENT, gastrointestinal system, reproductive system, skin and skin structure, infection or disseminated infection. 3. Blood Stream Infection with any other organism for collection of the limited data set

Exclusion criteria

Exclusion criteria: 1. Less than 18 years of age 2. Having cystic fibrosis 3. Having disease associated with human immunodeficiency virus 4. Patients on the end of care pathway 5. Duplicate organism (same organism within 14 days of previous blood culture) 6. Prisoners or young offenders in the custody of HM Prison Service in England or Wales

Design outcomes

Primary

MeasureTime frame
All-cause mortality and time to death (up to 28 days from when the blood samples was taken)

Secondary

MeasureTime frame
1. Resolution of fever (temperature =48 hours) and time to resolution of fever (up to 28 days from when the blood samples was taken) 2. Discharge from hospital and time to discharge (up to 28 days from when the blood samples was taken) 3. C. difficile infection (up to 28 days from when the blood samples was taken)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026